Group 1 - The core point of the article is that Jilin Aodong (SZ 000623) held its 11th Board of Directors meeting on November 24, 2025, to discuss the election of members for the specialized committees of the board [1] - For the first half of 2025, Jilin Aodong's revenue composition was as follows: 73.63% from the pharmaceutical industry, 16.59% from wholesale and retail of chain pharmacies, 7.39% from food, 1.76% from other industries, and 0.62% from other businesses [1] - As of the report date, Jilin Aodong's market capitalization was 22.7 billion yuan [1] Group 2 - The article also mentions that Dapeng Industrial's strategic placement benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a floating profit of 24.92 million yuan for the actual controller and his brother [1]
吉林敖东:11月24日召开董事会会议